|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.3 HKD | +2.68% |
|
-0.86% | -7.63% |
Essex Bio-Technology Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was HKD 1,317.71 million compared to HKD 1,637.66 million a year ago. Net income was HKD 225.41 million compared to HKD 345.97 million a year ago.
Basic earnings per share from continuing operations was HKD 0.3927 compared to HKD 0.6 a year ago. Diluted earnings per share from continuing operations was HKD 0.3828 compared to HKD 0.5813 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.63% | 167M | |
| -4.24% | 86.85B | |
| +2.76% | 40.16B | |
| -16.98% | 31.28B | |
| +57.86% | 25.27B | |
| -16.24% | 15.33B | |
| -9.12% | 11.96B | |
| -42.56% | 11.61B | |
| -17.10% | 11.69B | |
| +6.89% | 8.83B |
ESSEX BIO-TECHNOLOGY LIMITED 
